Canaccord Genuity Maintains a 'Hold' on AngioDynamics (ANGO); Bumping Estimates After Q4 Results

July 13, 2012 8:22 AM EDT Send to a Friend
Canaccord Genuity maintains a 'Hold' on AngioDynamics (NASDAQ: ANGO) price target of $14.50.

Analyst, Jason R. Mills, said, "ANGO ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login